Hematopoietic stem cells: Challenges to expectations

Current Opinion in Immunology

Volumn 9, Issue 2, 1997, Pages 216-221

  Morrison, Sean J ^a   Wright, Douglas E ^b   Cheshier, Samuel H ^b   Weissman, Irving L ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CYTOLOGY; GENE CONTROL; HEMATOPOIETIC STEM CELL; REVIEW;

EID: 0030991714     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80138-0     Document Type: Article

References (67)

1. Siminovitch L, McCulloch E, Till J. The distribution of colony-forming cells among spleen colonies. J Cell Comp Physiol. 62:1963;327-336.
2. Wu A, Till J, aiSiminovitch L, McCulloch E. A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J Cell Physiol. 69:1967;177-184.
3. Wu A, Till J, Siminovitch L, McCulloch E. Cytological evidence for a relationship between normal hematopoietic colony-forming cells and cells of the lymphoid system. J Exp Med. 127:1968;455-467.
4. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 241:1988;58-62.
5. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4:1990;220-232.
6. Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA. 88:1991;2788-2792.
7. Harrison DE, Zhong R. The same exhaustible multillineage precursor produces both myeloid and lymphoid cells as early as 3-4 weeks after marrow transplantation. Proc Natl Acad Sci USA. 89:1992;10134-10138.
8. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:1994;661-673.
9. Zijlmans JM, Visser JWM, Kleiverda K, Kluin PM, Willemze R, Fibbe WE. Modification of rhodamine staining with the use of verapamil allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA. 92:1995;8901-8905.
10. Moore MAS, Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Brit J Haematol. 18:1970;279-296.
11. Weissman I, Papaioannou V, Gardner R. Fetal hematopoietic origins of the adult hematolymphoid system. Clarkson B, Mark P, Till J. Differentiation of Normal and Neoplastic Hematopoietic Cells. 1978;33-47 Cold Spring Harbor Laboratory, New York. [Cold Spring Harbor Conferences on Cell Proliferation, vol 5].
12. Dieterlen-Lievre F. On the origin of haemopoietic stem cells in the avian embryo: an experimental approach. J Embryol Exp Morphol. 33:1975;607-619.
13. Muller AM, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity. 1:1994;291-301.
14. Godin I, Dieterlen-Lievre F, Cumano A. Emergence of multipotent hemopoietic cells in the yolk sac and paraortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc Natl Acad Sci USA. 92:1995;773-777.
15. of outstanding interest Cumano A, Dieterlen-Lievre F, Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell. 86:1996;907-916 The splanchnopleural mesoderm and yolk sac were dissected from embryos before the onset of circulation and were cultured. The splanchnopleural mesoderm gave rise to multipotent progenitor activity, whereas the yolk sac only gave rise to progenitors that exhibited restricted myeloid progenitor activity. Multipotent progenitor activity was only observed in the yolk sac after the onset of circulation, suggesting that the yolk sac is seeded by progenitors that form in the splanchnopleural mesoderm.
16. of outstanding interest Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 86:1996;897-906 This group reports complementary findings to those in [15] from mice at a somewhat later stage of development. The splanchnopleural mesoderm described in [15] gives rise to the aorta-gonad-mesonephros (AGM) described in [16]. This paper demonstrates long-term HSC activity in the AGM, but not the yolk sac, soon after the onset of circulation. Together the observations of these two groups [15,16] suggest that definitive HSCs form de novo only from the dorsal mesoderm; however, given previous inconsistent results, these results must be confirmed by other approaches.
17. of special interest Zon LI. Developmental biology of hematopoiesis. Blood. 86:1995;2876-2891 An excellent embryological review of the formation of the hematopoietic system, with a perspective that includes amphibians, birds, and mammals. Evidence is reviewed demonstrating that the relative roles of the dorsal and ventral mesoderm in early hematopoiesis varies between species. The review includes a summary of recent advances dissecting the genetics of HSC formation and provides insight into which model systems will yield future advances.
18. Tavassoli M. Embryonic and fetal hematopoiesis: an overview. Blood Cells. 1:1991;269-281.
19. of special interest Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47-57 SCL is the only gene that has been shown to be required for all hematopoiesis. Deficiencies in other genes have been shown to severely disrupt, but not to prevent, all hematopoiesis. SCL may be required for the formation of HSCs.
20. Okuda T, Van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
21. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent hematopoietic stem cells from multipotent progenitors (CFU-S). Nature. 347:1990;188-190.
22. lo cells. In addition to reproducing the high radioprotective activity of these cells, this paper shows that 80% of the cells formed colonies in methylcellulose in response to a combination of cytokines but that few colonies were formed in response to single cytokines that stimulate more differentiated progenitor cells.
23. -/lo cells that had a low level of Rhodamine 123. These cells were highly radioprotective. Together with the data from [22], the data from this study suggest that a maximum of one out of five intravenously injected cells is able to home to hematopoietic tissues and give rise to detectable numbers of progeny.
24. of special interest Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 88:1996;487-491 The authors purified a population of long-term reconstituting HSCs that had neither CFU-S nor radioprotective activity. These differences relative to previous papers [4,8,22,23] may be explained by the more exhaustive ablation of the hematopoietic systems of recipient mice by the administration of a cytotoxic drug followed by irradiation, or by the use of a different strain of donor mouse (DBA/2×C57BL/6 F1 mice versus C57BL/6 used by other groups). The HSC population purified by Jones et al. was also reported to lack the expression of surface markers shown by other groups to be expressed in all C57BL/6 HSCs.
25. lo cells also contained long-term HSCs, but were not assayed for radioprotection. Again, the conditions for hematopoietic ablation of recipient mice in radioprotection assays were more stringent than those used in previous studies reporting that long-term HSCs were radioprotective.
26. of special interest Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 2:1996;1011-1016 Although old and young bone marrow have similar progenitor activities, HSCs were seen to change in several ways as mice age. Most notably, they increase in number and are driven into cycle in old mice. By comparing the activities of HSCs in four different in vivo and in vitro assays of multipotent progenitor activity, this paper provides evidence that the efficiency with which HSCs engraft irradiated mice after intravenous injection can vary depending on donor age.
27. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/G-CSF induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA. 1997;. in press.
28. Wolf NS, Kone A, Priestley GV, Bartelmez SH. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol. 21:1993;614-622.
29. of special interest Muller-Sieburg CE, Riblet R. Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med. 183:1996;1141-1150 Two loci on chromosome 1 were found to correlate with multipotent progenitor frequency in mice. This is the first report of efforts to systematically identify genes that regulate HSC number. Because such genes presumably include factors that regulate self-renewal and survival, identification of these genes may advance efforts to expand HSCs ex vivo.
30. Van Zant G, Eldridge PW, Behringer RR, Dewey MJ. Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell. 35:1983;639-645.
31. Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, Thomas R, aiBroxmeyer HE, Cooper S, Hague N, Moore M, Lasky LA. Hematopoietic defects in mice lacking the sialomucin CD34. Blood. 87:1996;479-490.
32. Suzuki A, Andrew DP, Gonzalo J-A, Fukumoto M, Spellberg J, Hashiyama M, Takimoto H, Gerwin N, Webb I, Molineux G, et al. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90 kD protein. Blood. 87:1996;3550-3562.
33. Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, Sharkis SJ, May WS. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 84:1994;691-701.
34. Morel F, Szilvassy SJ, Travis M, Chen B, Galy A. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen. Blood. 88:1996;3774-3784.
35. - hematopoietic stem cell. Blood. 83:1994;1515-1526.
36. Randall TD, Lund FE, Howard MC, Weissman IL. Expression of murine CD38 defined a population of long-term reconstituting hematopoietic stem cells. Blood. 87:1996;4057-4067.
37. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, Weissman IL. Identification of a lineage of multipotent hematopoietic progenitors. Development. 1997;. in press.
38. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 91:1994;9857-9860.
39. of special interest Morrison S, Prowse KR, Ho P, Weissman I. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 5:1996;207-216 Telomere length has been proposed to act as a mitotic clock, regulating the proliferative potential of cells. Telomerase activity has been widely observed in immortal cells, but infrequently in normal somatic cells. This study reports that self-renewing but not non-self-renewing mouse hematopoietic cells, irrespective of differentiation state, expressed telomerase. In particular most HSCs but few non-self-renewing multipotent progenitors expressed telomerase. Thus the developmental characteristic most consistently associated with telomerase expression is self-renewal potential. Telomerase may be a conserved element of genetic programs to effect self-renewing divisions.
40. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:1994;143-156.
41. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci USA. 92:1995;10302-10306.
42. Bodine DM, Seidel NE, Zsebo KM, Orlic D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood. 82:1993;445-455.
43. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA. 90:1993;3760-3764.
44. of special interest Laterveer L, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood. 85:1995;2269-2275 The demonstration that HSCs can be mobilized within 30 minutes of administering cytokines dramatically restricts the models of regulatory features that can be proposed to be required for mobilization.
45. Laterveer L, Lindley IJD, Heemskerk DPM, Camps JAJ, Pauwels EKJ, Willemze R, Fibbe WE. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood. 87:1996;781-788.
46. Bodine D, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood. 88:1996;89-97.
47. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 352:1991;438-441.
48. Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med. 173:1991;599-607.
49. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood. 80:1992;388-395.
50. Jacobsen K, Kravitz J, Kincaid PW, Osmond D. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood. 87:1996;73-82.
51. Schweitzer KM, Drager AM, Van der Valk P, Thijsen SFT, Zevenbergen A, Theijsmeijer AP, Van der Schoot CE, Langenhuijsen MMAC. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol. 148:1996;165-175.
52. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA. 90:1993;9374-9378.
53. of special interest Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA. 92:1995;9647-9751 The disruption of the VLA-4/VCAM-1 interaction was shown to be sufficient to cause mobilization of hematopoietic progenitors from the bone marrow. Other groups have shown that HSCs express VLA-4 and that stroma express VCAM-1. Although it has not been proven that antibodies against VLA-4 cause mobilization by acting directly on progenitor cells, this is likely to be the most direct insight yet into the regulation of egress from and homing to the bone marrow.
54. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta-1 integrins. Nature. 380:1996;171-175.
55. Yang JT, Raybum H, Hynes RO. Cell adhesion events mediated by alpha4 integrins are essential in placental and cardiac development. Development. 121:1995;549-560.
56. Arroyo A, Yang JT, Rayburn H, Hynes RO. Differential requirements for alpha-4 integrins during fetal and adult hematopoiesis. Cell. 85:1996;997.
57. Lemischka IR, Raulet D, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 45:1986;917-927.
58. Harrison DE, Lemer C, Hoppe PC, Carlson GA, Alling D. Large numbers of primitive stem cells are active simultaneously in aggregated embryo chimeric mice. Blood. 69:1987;773-777.
59. Harrison DE, Astle CM, Lerner C. Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells. Proc Natl Acad Sci USA. 85:1988;822-826.
60. Pietrzyk ME, Priestley GV, Wolf NS. Normal cycling patterns of hematopoietic stem cell subpopulations: an assay using long-term in vivo BrdU infusion. Blood. 66:1985;1460-1462.
61. Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood. 86:1995;1600-1605.
62. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood. 87:1996;1644-1653.
63. Siegert W, Serke S. Cytokine mobilized blood CD34-expressing cells are not cycling. Bone Marrow Transpl. 17:1996;467-470.
64. 1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood. 89:1997;465-472.
65. Dunn TB. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst. 14:1954;1281-1433.
66. + cells from patients with chronic myeloid leukemia. Blood. 88:1996;1796-1804.
67. De Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hemopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood. 1997;. in press.